Serum Institute launches India's first fully indigenously developed pneumococcal vaccine

PNEUMOSIL has been developed through a collaboration spanning over a decade among Serum Institute of India Pvt Ltd, PATH and Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Mhj3HZ
via IFTTT